BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Athenex. to Report Third Quarter 2017 Earnings Results on November 9, 2017

  The Company will host a conference call the same day at 9:00 a.m. ET.

  October 30, 2017

   · 

  2 min read
• Business

  Optinose Expands Leadership Team With Key Hires

  The company announced the addition of five key members to the leadership team.

  October 30, 2017

   · 

  6 min read
• Drug Development

  OBI Pharma Announces OBI-3424 Results From the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

  Overall study results demonstrated that OBI-3424 was well-tolerated, with only a 2.8% toxicity rate in the drug-treated groups.

  October 30, 2017

   · 

  4 min read
• BioForest

  BioLife Solutions Receives $1.9M From Exercise of Warrants

  BioLife Solutions today announced the receipt of$1.3M through the cash exercise of 393,070 common stock purchase warrants.

  October 30, 2017

   · 

  2 min read
• Drug Development

  Merrimack Receives Orphan Drug Designation for MM-121 for the Treatment of Heregulin Positive Non-Small Cell Lung Cancer

  Merrimack today announced that the FDA has granted orphan drug designation to MM-121, its investigational drug candidate, a fully human monoclonal antibody.

  October 30, 2017

   · 

  5 min read
• NeuroCog Trials Awarded NIH Grant to Validate Performance-Based Measure of Functioning in MCI Alzheimer’s Disease

  NeuroCog Trials today announced it received a 2017 Fast Track grant from the NIH to study the validation of a performance-based measure of functioning in Mild Cognitive Impairment and early ALZ’s disease using NCT’s proprietary technology, the Virtual Reality Functional Capacity Assessment Tool.

  October 30, 2017

   · 

  2 min read
• Business

  Michael J. Fox Foundation and 23andMe Announce Collaboration to Capture Parkinson’s Experience at Scale and Amplify Patient Voice in Research and Care

  The Michael J. Fox Foundation for Parkinson’s Research and 23andMe announced a collaboration to build a large, diverse cohort of both patients and control volunteers who have consented to participate in research.

  October 30, 2017

   · 

  6 min read
• Business

  GRAMINEX Expands Its Partnership With IDIPharma After Clinical Study Publication.

  IDIPharma and Graminex have agreed to expand clinical research on Graminex Flower Pollen Extract.

  October 30, 2017

   · 

  2 min read
• Drug Development

  Biothera Pharmaceuticals Presents Preclinical Data Showing Imprime PGG Activates Natural Killer Cell-Mediated Tumor Killing

  The data will be presented at the AACR-NCI-EORTC International Conference.

  October 30, 2017

   · 

  2 min read
• Drug Development

  New Preclinical Data Suggest That Cellectar Biosciences’ PDC Platform Provides Enhanced Outcomes in Combination With External Radiation

  Investigators observed that CLR 127 was taken up and retained in the tumor cells at 6-10 fold higher level than normal tissue and sensitized the tumor cells to external radiation.

  October 30, 2017

   · 

  4 min read